# Perfusion Assessment With Contrast-Enhanced EUS in Locally Advanced and Metastatic Pancreatic Cancer

> **NCT03513198** · — · UNKNOWN · sponsor: **University of Medicine and Pharmacy Craiova** · enrollment: 200 (estimated)

## Conditions studied

- Pancreas Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Endoscopic ultrasound (including fine needle aspiration)
- **OTHER:** Contrast-enhanced endoscopic ultrasound (CE-EUS)
- **OTHER:** Endoscopic ultrasound elastography (EG-EUS)
- **DIAGNOSTIC_TEST:** Contrast-enhanced computed tomography (CT)

## Key facts

- **NCT ID:** NCT03513198
- **Lead sponsor:** University of Medicine and Pharmacy Craiova
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-01
- **Primary completion:** 2023-02
- **Final completion:** 2023-02
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2018-05-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03513198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03513198, "Perfusion Assessment With Contrast-Enhanced EUS in Locally Advanced and Metastatic Pancreatic Cancer". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT03513198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*